275 related articles for article (PubMed ID: 21492457)
1. Inhibition of nuclear factor kappa-B signaling reduces growth in medulloblastoma in vivo.
Spiller SE; Logsdon NJ; Deckard LA; Sontheimer H
BMC Cancer; 2011 Apr; 11():136. PubMed ID: 21492457
[TBL] [Abstract][Full Text] [Related]
2. Bortezomib induces apoptosis and growth suppression in human medulloblastoma cells, associated with inhibition of AKT and NF-ĸB signaling, and synergizes with an ERK inhibitor.
Yang F; Jove V; Chang S; Hedvat M; Liu L; Buettner R; Tian Y; Scuto A; Wen W; Yip ML; Van Meter T; Yen Y; Jove R
Cancer Biol Ther; 2012 Apr; 13(6):349-57. PubMed ID: 22313636
[TBL] [Abstract][Full Text] [Related]
3. C086, a novel analog of curcumin, induces growth inhibition and down-regulation of NFκB in colon cancer cells and xenograft tumors.
Chen C; Liu Y; Chen Y; Xu J
Cancer Biol Ther; 2011 Nov; 12(9):797-807. PubMed ID: 21900746
[TBL] [Abstract][Full Text] [Related]
4. An anti-leishmanial thiadiazine agent induces multiple myeloma cell apoptosis by suppressing the nuclear factor kappaB signalling pathway.
Chen G; Han K; Xu X; Du X; Zhang Z; Tang J; Shi M; Wang M; Li J; Cao B; Mao X
Br J Cancer; 2014 Jan; 110(1):63-70. PubMed ID: 24231956
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells.
Khanbolooki S; Nawrocki ST; Arumugam T; Andtbacka R; Pino MS; Kurzrock R; Logsdon CD; Abbruzzese JL; McConkey DJ
Mol Cancer Ther; 2006 Sep; 5(9):2251-60. PubMed ID: 16985059
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib inhibits proteasomal degradation of IκBα and induces mitochondrial dependent apoptosis in activated B-cell diffuse large B-cell lymphoma.
Bu R; Hussain AR; Al-Obaisi KA; Ahmed M; Uddin S; Al-Kuraya KS
Leuk Lymphoma; 2014 Feb; 55(2):415-24. PubMed ID: 23697845
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib sensitizes malignant human glioma cells to TRAIL, mediated by inhibition of the NF-{kappa}B signaling pathway.
Jane EP; Premkumar DR; Pollack IF
Mol Cancer Ther; 2011 Jan; 10(1):198-208. PubMed ID: 21220502
[TBL] [Abstract][Full Text] [Related]
8. Bortezomib-enhanced radiosensitization through the suppression of radiation-induced nuclear factor-κB activity in human oral cancer cells.
Tamatani T; Takamaru N; Hara K; Kinouchi M; Kuribayashi N; Ohe G; Uchida D; Fujisawa K; Nagai H; Miyamoto Y
Int J Oncol; 2013 Mar; 42(3):935-44. PubMed ID: 23340716
[TBL] [Abstract][Full Text] [Related]
9. Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells.
Hideshima T; Ikeda H; Chauhan D; Okawa Y; Raje N; Podar K; Mitsiades C; Munshi NC; Richardson PG; Carrasco RD; Anderson KC
Blood; 2009 Jul; 114(5):1046-52. PubMed ID: 19436050
[TBL] [Abstract][Full Text] [Related]
10. PELP1 signaling contributes to medulloblastoma progression by regulating the NF-κB pathway.
Luo Y; Li M; Pratap UP; Viswanadhapalli S; Liu J; Venkata PP; Altwegg KA; Palacios BE; Li X; Chen Y; Rao MK; Brenner AJ; Sareddy GR; Vadlamudi RK
Mol Carcinog; 2020 Mar; 59(3):281-292. PubMed ID: 31872914
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the neuronal NFκB pathway attenuates bortezomib-induced neuropathy in a mouse model.
Alé A; Bruna J; Calls A; Karamita M; Haralambous S; Probert L; Navarro X; Udina E
Neurotoxicology; 2016 Jul; 55():58-64. PubMed ID: 27211850
[TBL] [Abstract][Full Text] [Related]
12. Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo.
Lee SJ; Krauthauser C; Maduskuie V; Fawcett PT; Olson JM; Rajasekaran SA
BMC Cancer; 2011 Apr; 11():144. PubMed ID: 21501498
[TBL] [Abstract][Full Text] [Related]
13. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
[TBL] [Abstract][Full Text] [Related]
14. Blockade of estrogen receptor signaling inhibits growth and migration of medulloblastoma.
Belcher SM; Ma X; Le HH
Endocrinology; 2009 Mar; 150(3):1112-21. PubMed ID: 19008315
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas.
Künkele A; De Preter K; Heukamp L; Thor T; Pajtler KW; Hartmann W; Mittelbronn M; Grotzer MA; Deubzer HE; Speleman F; Schramm A; Eggert A; Schulte JH
Neuro Oncol; 2012 Jul; 14(7):859-69. PubMed ID: 22591662
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the NFκB pathway drives differentiating glioblastoma-initiating cells into senescence both in vitro and in vivo.
Nogueira L; Ruiz-Ontañon P; Vazquez-Barquero A; Lafarga M; Berciano MT; Aldaz B; Grande L; Casafont I; Segura V; Robles EF; Suarez D; Garcia LF; Martinez-Climent JA; Fernandez-Luna JL
Oncogene; 2011 Aug; 30(32):3537-48. PubMed ID: 21423202
[TBL] [Abstract][Full Text] [Related]
17. Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma.
Faria CC; Golbourn BJ; Dubuc AM; Remke M; Diaz RJ; Agnihotri S; Luck A; Sabha N; Olsen S; Wu X; Garzia L; Ramaswamy V; Mack SC; Wang X; Leadley M; Reynaud D; Ermini L; Post M; Northcott PA; Pfister SM; Croul SE; Kool M; Korshunov A; Smith CA; Taylor MD; Rutka JT
Cancer Res; 2015 Jan; 75(1):134-46. PubMed ID: 25391241
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action and therapeutic efficacy of Aurora kinase B inhibition in MYC overexpressing medulloblastoma.
Diaz RJ; Golbourn B; Faria C; Picard D; Shih D; Raynaud D; Leadly M; MacKenzie D; Bryant M; Bebenek M; Smith CA; Taylor MD; Huang A; Rutka JT
Oncotarget; 2015 Feb; 6(5):3359-74. PubMed ID: 25739120
[TBL] [Abstract][Full Text] [Related]
19. Dimethyl Fumarate Inhibits the Nuclear Factor κB Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein.
Kastrati I; Siklos MI; Calderon-Gierszal EL; El-Shennawy L; Georgieva G; Thayer EN; Thatcher GR; Frasor J
J Biol Chem; 2016 Feb; 291(7):3639-47. PubMed ID: 26683377
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib induces nuclear translocation of IκBα resulting in gene-specific suppression of NF-κB--dependent transcription and induction of apoptosis in CTCL.
Juvekar A; Manna S; Ramaswami S; Chang TP; Vu HY; Ghosh CC; Celiker MY; Vancurova I
Mol Cancer Res; 2011 Feb; 9(2):183-94. PubMed ID: 21224428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
